Richard A Waldron's most recent trade in BioAtla Inc was a trade of 2,371 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on May 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 31 May 2025 | 2,371 | 340,892 | - | 0.4 | 970 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 100,000 | 333,263 | - | 0 | Common Stock | |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.46 per share. | 15 Feb 2025 | 10,887 | 233,263 | - | 0.5 | 5,008 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 106,000 | 230,923 | - | 0 | Common Stock | |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 31 Jul 2023 | 970 | 127,833 | - | 3.0 | 2,900 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 30 Jun 2023 | 970 | 125,780 | - | 3 | 2,910 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.15 per share. | 31 May 2023 | 970 | 126,750 | - | 3.2 | 3,056 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 30 Apr 2023 | 970 | 127,720 | - | 3.4 | 3,269 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2023 | 970 | 128,690 | - | 2.7 | 2,600 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.98 per share. | 09 Feb 2023 | 970 | 129,660 | - | 3.0 | 2,891 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.79 per share. | 31 Jan 2023 | 1,144 | 130,630 | - | 3.8 | 4,336 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.25 per share. | 31 Dec 2022 | 970 | 131,774 | - | 8.3 | 8,003 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 30 Nov 2022 | 970 | 132,744 | - | 11.0 | 10,680 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.89 per share. | 31 Oct 2022 | 970 | 123,714 | - | 6.9 | 6,683 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 30 Sep 2022 | 970 | 124,684 | - | 7.7 | 7,469 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.71 per share. | 31 Aug 2022 | 970 | 125,654 | - | 8.7 | 8,449 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 31 Jul 2022 | 970 | 126,624 | - | 3.4 | 3,298 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. | 30 Jun 2022 | 970 | 127,594 | - | 2.9 | 2,765 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 May 2022 | 970 | 128,564 | - | 2.4 | 2,338 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 30 Apr 2022 | 970 | 129,534 | - | 3.5 | 3,376 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.00 per share. | 31 Mar 2022 | 970 | 130,504 | - | 5 | 4,850 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.48 per share. | 28 Feb 2022 | 970 | 131,474 | - | 6.5 | 6,286 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 31 Jan 2022 | 1,150 | 132,444 | - | 9.6 | 10,994 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.63 per share. | 31 Dec 2021 | 1,391 | 133,078 | - | 19.6 | 27,305 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 29 Nov 2021 | 4,599 | 148,659 | - | 23.9 | 109,870 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 22 Nov 2021 | 3,669 | 159,296 | - | 24.3 | 89,102 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 22 Nov 2021 | 3,626 | 162,965 | - | 26.2 | 95,128 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 22 Nov 2021 | 2,101 | 157,195 | - | 26.0 | 54,700 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.05 per share. | 22 Nov 2021 | 1,459 | 155,736 | - | 24.1 | 35,093 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 22 Nov 2021 | 1,354 | 154,382 | - | 25.0 | 33,849 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.77 per share. | 22 Nov 2021 | 1,124 | 153,258 | - | 25.8 | 28,967 | Common Stock |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 31,976 | 166,591 | - | 0 | Common Stock | |
| BioAtla Inc | Richard A. Waldron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 30,988 | 30,988 | - | - | Employee Stock Option (right to buy) |